Primary and secondary prevention of cerebral ischemia: joint guidelines of the German Society of Neurology (DGN) and German Stroke Society (DSG)

Classification of level of evidence: ↑↑ Efficacy and usefulness is well supported by multiple appropriate clinical studies (i.e. controlled randomized trials), either one or more metaanalyses or systematic reviews. ↑Efficacy and usefulness is supported by at least one appropriate clinical study (i.e...

Full description

Saved in:
Bibliographic Details
Main Authors: Diener, Hans-Christoph (Author) , Aichner, F. (Author) , Bode, C. (Author) , Böhm, M. (Author) , Eckstein, H.-H. (Author) , Einhäupl, K. (Author) , Endres, M. (Author) , Forsting, F. (Author) , Gesenhues, S. (Author) , Grond, M. (Author) , Haberl, R. L. (Author) , Hacke, Werner (Author) , Hennerici, M. (Author) , Lyrer, P. (Author) , Link, A. (Author) , Ringelstein, B. (Author) , Ringleb, Peter A. (Author) , Schrader, J. (Author) , Weimar, C. (Author)
Format: Article (Journal)
Language:English
Published: 21. Mai 2010
In: Aktuelle Neurologie
Year: 2010, Volume: 37, Issue: 4, Pages: e2-e22
ISSN:1438-9428
DOI:10.1055/s-0029-1223537
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0029-1223537
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1223537
Get full text
Author Notes:H.-C. Diener, F. Aichner, C. Bode, M. Böhm, H.-H. Eckstein, K. Einhäupl, M. Endres, F. Forsting, S. Gesenhues, M. Grond, R.L. Haberl, W. Hacke, M. Hennerici, P. Lyrer, A. Link, B. Ringelstein, P.A. Ringleb, J. Schrader, C. Weimar
Description
Summary:Classification of level of evidence: ↑↑ Efficacy and usefulness is well supported by multiple appropriate clinical studies (i.e. controlled randomized trials), either one or more metaanalyses or systematic reviews. ↑Efficacy and usefulness is supported by at least one appropriate clinical study (i.e. controlled randomized trial). ↓↓ Lack of efficacy is well supported by one or more appropriate clinical studies (i.e. controlled randomized trial), either one or more metaanalyses or systematic reviews. ↔ No study results exist to prove any benefit or harm. This can be due lack of appropriate studies, or several studies with controversial results.
Item Description:Gesehen am 02.02.2023
Physical Description:Online Resource
ISSN:1438-9428
DOI:10.1055/s-0029-1223537